Advances in the Treatment of Multiple myeloma

Zhang Xiao Yun

Volume 37 Issue 10

Sep. 2020

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2016 > 37(10):

Zhang Xiao Yun . Advances in the Treatment of Multiple myeloma[J]. Journal of Kunming Medical University, 2016, 37(10).

Citation:

Zhang Xiao Yun . Advances in the Treatment of Multiple myeloma[J]. Journal of Kunming Medical University, 2016, 37(10).

Zhang Xiao Yun . Advances in the Treatment of Multiple myeloma[J]. Journal of Kunming Medical University, 2016, 37(10).

Citation:

Zhang Xiao Yun . Advances in the Treatment of Multiple myeloma[J]. Journal of Kunming Medical University, 2016, 37(10).

PDF( 542 KB)

Advances in the Treatment of Multiple myeloma

Zhang Xiao Yun

(1)Dept. of The Blood Oncology,The 2nd People’s Hospital of Qujing,Qujing Yunnan 655000;2)Dept. of Hematology,The 1st Affiliated of Kunming Medical University/ Blood Disease Research Center of Yunnan Province,Kunming Yunnan 650000,China)

Publish Date: 2020-09-27

Abstract

Abstract

［Abstract］Multiple myeloma is a monoclonal plasma cell malignant proliferative disease，accounting for about 10% of malignant tumors of blood system. In recent years，due to the application of hematopoietic stem cell transplantation and the application of MDT by combining new drug such as thalidomide, lenalidomide and bortezomib,the average survival of MM patients was significantly longer than before. The treatment strategy should be individualized before treatment according to the patient's age，physical condition and complications .In this paper，the treatment strategy of multiple myeloma patients were reviewed.

FullText(HTML)

References(0)

References

Relative Articles(20)

Relative Articles

[1]	Mengjun LIU, Shoukun CHEN, Liuxin HAN, Jing PENG, Weisha ZHOU, Yunying ZHANG, Yiying WANG, Jiawei XIA. Efficacy of Roxadustat in the Maintenance Hemodialysis of HIV/AIDS Patients Resistant to EPO. Journal of Kunming Medical University, 2024, 45(8): 139-144. doi: 10.12259/j.issn.2095-610X.S20240820
[2]	Jian-ping LI, Xue-ren GAO, Xiao-yan ZHANG, Ping CHEN, Su-rong CHEN, Wei-gang BIAN, Zhi-jun HUANG. Efficacy and Safety of Capecitabine Combined with Bevacizumab or Single Agent of Capecitabine as Maintenance Therapy for Advanced Colorectal Cancer. Journal of Kunming Medical University, 2021, 42(9): 119-126. doi: 10.12259/j.issn.2095-610X.S20210908
[3]	Rong Dong Jing , Zhang Yu An , Zhang Yu Lin , Xiao Yi , Chang Yan Ping . . Journal of Kunming Medical University, 2020, 41(04): 121-126.
[4]	Li Jing Juan , Chen Guo Shu , Pan Si Min , Pu Li Sha , Li Jun . . Journal of Kunming Medical University, 2019, 40(01): 48-52.
[5]	Li Mei , Huang Nan , Yang Chun Xia , Chen Wei . . Journal of Kunming Medical University, 2019, 40(10): 125-130.
[6]	Lei Hong Tao , Yang Yao , Gan Yuan , Qiao Jing Jing , Bi Yan , Zhou Qing , Liu Chang , Li Wen Na , Tang Song Yuan . . Journal of Kunming Medical University, 2018, 39(12): 108-114.
[7]	Bai Yi Hua . Effect of Depression on the Incidence of Osteoporosis in Patients with Maintenance Peritoneal Dialysis. Journal of Kunming Medical University,
[8]	Lu Rong . . Journal of Kunming Medical University,
[9]	Li Wen Hong . . Journal of Kunming Medical University,
[10]	Xu Yan . . Journal of Kunming Medical University,
[11]	Li Wu . . Journal of Kunming Medical University, 2014, 35(12): 1-1.
[12]	Cai Bi Bo . . Journal of Kunming Medical University,
[13]	Cai Yan . . Journal of Kunming Medical University,
[14]	ShambhuKumarRay. . Journal of Kunming Medical University,
[15]	Zhang Xiao Qing . . Journal of Kunming Medical University,
[16]	Yin Liang . . Journal of Kunming Medical University,
[17]	Liu Jian Xing . . Journal of Kunming Medical University,
[18]	. . Journal of Kunming Medical University,
[19]	Xiong Guo Hua . . Journal of Kunming Medical University,
[20]	Cao Hong Ming . . Journal of Kunming Medical University,